Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
Steger, G.G., Greil, R., Lang, A., Rudas, M., Fitzal, F., Mlineritsch, B., Hartmann, B.L., Bartsch, R., Melbinger, E., Hubalek, M., Stoeger, H., Dubsky, P., Ressler, S., Petzer, A.L., Singer, C.F., Muss, C., Jakesz, R., Gampenrieder, S.P., Zielinski, C.C., Fesl, C., Gnant, M.
Published in Annals of oncology (01.02.2014)
Published in Annals of oncology (01.02.2014)
Get full text
Journal Article
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
Gampenrieder, S P, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R
Published in The pharmacogenomics journal (01.07.2017)
Published in The pharmacogenomics journal (01.07.2017)
Get full text
Journal Article
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
Gampenrieder, S.P., Dezentjé, V., Lambertini, M., de Nonneville, A., Marhold, M., Le Du, F., Cortés Salgado, A., Alpuim Costa, D., Vaz Batista, M., Chic Ruché, N., Tinchon, C., Petzer, A., Blondeaux, E., Del Mastro, L., Targato, G., Bertucci, F., Gonçalves, A., Viret, F., Bartsch, R., Mannsbart, C., Deleuze, A., Robert, L., Saavedra Serrano, C., Gion Cortés, M., Sampaio-Alves, M., Vitorino, M., Pecen, L., Singer, C., Harbeck, N., Rinnerthaler, G., Greil, R., Balic, Marija, Heibl, Sonja, Zabernigg, August Felix, Egle, Daniel, Sandholzer, Margit, Roitner, Florian, Andel, Johannes, Pichler, Petra, Hager, Christopher, Knauer, Michael, Hubalek, Michael, Bighin, Claudia, De Laurentiis, Michelino, De Placido, Sabino, Puglisi, Fabio, Boni, Luca, de Gregorio, Amelie, Degenhardt, Tom, Formisano, Luigi, Beelen, Karin, Robinson, Timothy, Fitzpatrick, Amanda, Dieras, Veronique, Muller, Volkmar, Gennari, Alessandra, Linn, Sabine, Braga, Sofia, Cortes, Javier, Palmieri, Carlo
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
Razis, E., Escudero, M.J., Palmieri, C., Mueller, V., Bartsch, R., Rossi, G., Gampenrieder, S.P., Kolberg, H.C., Zdenkowski, N., Pavic, M., Connolly, R.M., Rosset, L., Arcuri, J., Tesch, H., Vallejos, C., Retamales, J., Musolino, A., Del Mastro, L., Christodoulou, C., Aebi, S., Paluch-Shimon, S., Gupta, S., Ohno, S., Macpherson, I., Ekholm, M., Zaman, K., Vidal, M., Chakiba, C., Fumagalli, D., Thulin, A., Witzel, I., Kotecki, N., Gil-Gil, M., Linderholm, B.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
351PImpact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
Gampenrieder, S P P, Rinnerthaler, G, Petzer, A, Tinchon, C, Fuchs, D, Balic, M, Heibl, S, Rumpold, H, Egle, D, Zabernigg, A F, Singer, C F, Andel, J, Hubalek, M, Knauer, M, Greil, R
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G., Gampenrieder, S.P., Voskova, D., Petzer, A., Hubalek, M., Petru, E., Hartmann, B., Andel, J., Balic, M., Melchardt, T., Mlineritsch, B., Greil, R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
MiR-16 is the most stable-expressed housekeeping microRNA in breast cancer tissues from primary and metastatic sites
Rinnerthaler, G., Hackl, H., Hamacher, F., Gampenrieder, S.P., Hufnagl, C., Romeder, F., Monzo Fuentes, C., Hauser-Kronberger, C., Mlineritsch, B., Greil, R.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Abstract P3-10-07: A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, SP, Angela, R, Rinnerthaler, G, Hackl, H, Steiner, M, Pulverer, W, Weinhaeusel, A, Klinglmayr, E, Karl, T, Ilic, S, Hufnagl, C, Hauser-Kronberger, C, Egle, A, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract OT3-07-01: Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Voskova, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Predicting response to second-line trastuzumab-based therapy in patients (pts) with HER2-positive advanced breast cancer (ABC)
Bartsch, R., Wenzel, C., Pluschnig, U., Dubsky, P., Gampenrieder, S. P., Rudas, M., Mader, R., Gnant, M., Zielinski, C. C., Steger, G. G.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Abstract P5-15-13: Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G, Gampenrieder, SP, Voskova, D, Petzer, A, Hubalek, M, Petru, E, Hartmann, B, Andel, J, Balic, M, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P6-07-10: DNA methylation signature predicting bevacizumab efficacy in metastatic breast cancer
Gampenrieder, SP, Rinnerthaler, G, Pulverer, W, Weinhäusel, A, Hufnagl, C, Hackl, H, Hauser-Kronberger, C, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P4-02-02: Contrast-enhanced MRI does not accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy in early or locally advanced breast cancer
Gampenrieder, SP, Peer, A, Weismann, C, Meissnitzer, M, Rinnerthaler, G, Webhofer, J, Westphal, T, Popovscaia, M, Meissnitzer, T, Reitsamer, R, Hauser-Kronberger, C, Egger, H, Hergan, K, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract OT2-07-11: Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, a phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Pusch, R, Fridrik, M, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, C, Bartsch, R, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P1-13-10: Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G, Gampenrieder, SP, Fridrik, M, Petzer, A, Hubalek, M, Petru, E, Jäger, T, Andel, J, Balic, M, Ulmer, H, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P3-07-43: DNA methylation patterns correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
Gampenrieder, SP, Rinnerthaler, G, Weinhäusel, A, Pulverer, W, Hugnagl, C, Hackl, H, Romeder, F, Monzo Fuentes, C, Hauser-Kronberger, C, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P1-08-32: Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Muß, C, Pircher, M, Ressler, S, Kronberger, C, Mlineritsch, B, Greil, R
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
Gnant, Michael, Frantal, Sophie, Pfeiler, Georg, Steger, Guenther G, Egle, Daniel, Greil, Richard, Fitzal, Florian, Wette, Viktor, Balic, Marija, Haslbauer, Ferdinand, Melbinger-Zeinitzer, Elisabeth, Bjelic-Radisic, Vesna, Artner-Matuschek, Silvia, Kainberger, Franz, Ritter, Magdalena, Rinnerthaler, Gabriel, Sevelda, Paul, Bergh, Jonas, Kacerovsky-Strobl, Stephanie, Suppan, Christoph, Brunner, Christine, Deutschmann, Christine, Gampenrieder, Simon P, Fohler, Hannes, Jakesz, Raimund, Fesl, Christian, Singer, Christian
Published in NEJM evidence (01.12.2022)
Published in NEJM evidence (01.12.2022)
Get more information
Journal Article